Service advice and planning
39 results
Applied filters
Additional considerations for single or multi-centre trials
29 April 2026Ensure the correct process is followed depending on whether it is a single or multi-centre trial sponsored by an NHS organisation.
Constructing a pharmacy manual for clinical trials
29 April 2026Sponsor pharmacy should construct a pharmacy manual when required by the sponsor to facilitate IMP and NIMP management by the different delivery location sites.
Legal mechanisms to supply and administer medicines to individuals
1 April 2026The main legal mechanisms used to supply and/or administer medicines are explained and considerations suggested for the most appropriate option(s)
Supply and administration of medicines by staff group (P to Z)
1 April 2026Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.
Supply and administration of medicines by staff group (H to O)
1 April 2026Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.
Supply and administration of medicines by staff group (A to G)
1 April 2026Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.
Pharmacy technicians working under Patient Group Directions
1 April 2026Useful resources and further information for pharmacy technicians working under PGDs
Managing controlled drugs for dental teams
16 March 2026This article provides an overview of controlled drug (CD) management for dental teams
Exagamglogene autotemcel (Casgevy®)
13 February 2026This document highlights key areas where Chief Pharmacists should focus pharmaceutical expertise prior to implementation of exagamglogene autotemcel.
In-vivo GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing in-vivo genetically modified organism (GMO) gene therapy.